Naloxone availability debated amid rising opioid overdose deaths

Campaigners are calling for naloxone, a life-saving medication used to reverse opioid overdoses, to be made available over the counter to combat rising drug-related deaths. In the United Kingdom, drug-related fatalities have doubled since 2012, reaching 5,448 deaths in England and Wales in 2025. Advocates from organizations such as Release and the Transform Drug Policy Foundation argue that the current restriction of the drug to police and paramedics is insufficient given the potency of synthetic opioids like fentanyl.

Sharon Hodgson MP, the undersecretary of state for health and prevention, stated that naloxone is a key part of the government's strategy to reduce deaths. However, she noted that transitioning to over-the-counter status would require manufacturer applications and assessments by the Medicines and Healthcare products Regulatory Agency.

In the United States, naloxone has already seen a shift toward becoming a pillar of harm reduction. It works within minutes by displacing opioid molecules from receptors in the brain stem that regulate breathing. While it can prevent immediate death during an overdose, it does not treat the underlying addiction.